GEMTUZUMAB OZOGAMICIN, FLUDARABINE, AND TOTAL-BODY IRRADIATION FOLLOWED BY PERIPHERAL STEM CELL OR BONE MARROW TRANSPLANTATION IN TREATING PATIENTS WITH ADVANCED ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME: